At meeting held on 17 October 2022
The Board of Glaxosmithkline Pharmaceuticals at its meeting held on 17 October 2022 has approved the appointment of Bhushan Akshikar (DIN: 09112346) as a Managing Director. He succeeds Sridhar Venkatesh who is moving to a new senior role within GSK Group effective 1 December 2022.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
